Risk Prediction for Secondary Events in Adults with Arteriosclerotic Cardiovascular Disease (ASCVD)
Research Grant
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
December 15, 2015
End Date
June 30, 2021
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
December 15, 2015
End Date
June 30, 2021